University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 9 of 13
Bone, Endocrine and Lifestyle Longitudinal Study
NCT02063074
Study of Mobile Phone Delivered Intervention to Reduce Alcohol Consumption
NCT02158949
Reducing the Duration of Untreated Psychosis
NCT03102151
Guided Imagery Lifestyle Intervention to Promote Health and Prevent Diabetes in Youth
NCT02088294
Project Bridge: Peer Health Navigator Intervention
NCT02022462
Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
NCT02370290
Triggers and Responses to Simulator Sickness in Videogame Players
NCT02122354
Nattokinase Atherothrombotic Prevention Study
NCT02080520
Clinical Evaluation of BackStop in Patients Undergoing Ureteroscopic Lithotripsy
NCT02122341
Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study
NCT02091921
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
NCT03563651
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
NCT02079181
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
NCT01767909
Mindfulness-Based Exercise Video in Educating Hispanic/Latino Patients With Colorectal Cancer and Their Caregivers
NCT02057991
Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery
NCT02067884
Nanopulse Efficacy Study for the Treatment of Common Warts
NCT02650466
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
NCT01712815
Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors
NCT01957995
Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01866423
A Helping Hand Among Low-Income Patients
NCT02147522
Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city Patients
NCT01945996
Group Self-Management of Depression and Medical Illness
NCT02017262
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
NCT01871571
Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.
NCT02225977
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
NCT01873833
Resistance Training and Protein Supplementation for Prostate Cancer Survivors
NCT01909440
Cilostazol and Its Effects on Resumption of Meiosis in the Human Ovary
NCT01915069
Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)
NCT02094755
Beta Cell Restoration Through Fat Mitigation
NCT01763346
Reducing PTSD in Hospitalized Burn Patients
NCT02026037
Effects of Obesity on Pharmacokinetics of the Levonorgestrel Emergency Contraceptive Pill
NCT02104609
Moderate Versus Aggressive Fluids for Acute Pancreatitis
NCT01761539
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
NCT01801046
Safety and Effectiveness Study: Role Playing Game for Friends and Family of Service Members
NCT01807806
Multi-cycle Prolon Diet
NCT02158897
Laser Versus Mechanical Lithotripsy of Bile Duct Stones
NCT01759979
Light-Scattering Spectroscopy for Detection of Breast Cancer
NCT01755208
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer
NCT02370264
A Study of Brain Aging in Vietnam War Veterans
NCT01687153
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
NCT01642342
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
NCT01649258
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
NCT01676818
Text Message Appointment Reminders
NCT01676337
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
NCT01723917
Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
NCT01758549
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
NCT01469338
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
NCT01592097
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
NCT01667978
Exercise Program for Early Breast Cancer Survivors
NCT01140282
Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
NCT03107689
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.